Interleukin 10: A New Risk Marker for the Development of Restenosis After Percutaneous Coronary Intervention

Genes and Immunity - United Kingdom
doi 10.1038/sj.gene.6364343
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

High Serum Concentration of Sulfatide Is a Risk Factor for Restenosis in Patients With Coronary Heart Disease After Percutaneous Coronary Intervention

Journal of Postgenomics Drug & Biomarker Development
2015English

Restenosis After Percutaneous Transluminal Coronary Angioplasty in the Elderly. Risk Factor Analysis.

Japanese Journal of Geriatrics
GerontologyGeriatrics
1995English

Predictors of In-Stent Restenosis in Patients Undergoing Percutaneous Coronary Intervention

Demiroğlu Bilim University Florence Nightingale Journal of Medicine
2019English

The Prognostic Value of IL-8 for Cardiac Events and Restenosis in Patients With Coronary Heart Diseases After Percutaneous Coronary Intervention

Japanese Heart Journal
2003English

Genetic Inflammatory Factors Predict Restenosis After Percutaneous Coronary Interventions

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Treatment of OSA Reduces the Risk of Repeat Revascularization After Percutaneous Coronary Intervention

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2015English

Does a Well Developed Collateral Circulation Predispose to Restenosis After Percutaneous Coronary Intervention? An Intravascular Ultrasound Study

Heart
Cardiovascular MedicineCardiology
2005English

Definition of Restenosis After Percutaneous Transluminal Coronary Angioplasty: A Quickly Evolving Concept

Journal of Interventional Cardiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
1991English

Percutaneous Coronary Intervention: Safety of Methotrexate and Its Possible Benefits on Restenosis After Bare-Metal Stent Deployment

Cardiology Research
Cardiovascular MedicineCardiology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy